Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review

    April 2026 in “ Dermatology and Therapy ”
    D Ramos-Rodríguez, Daniel Javier Sánchez-Báez, Patricia Cabrera-García … Juan Jimenez-Cauhe
    Studysummary This paper argues that androgenetic alopecia in transgender and gender-diverse individuals is clinically significant, suggesting individualized and gender-affirming treatment approaches, with oral minoxidil as a key therapy.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 48

    1. Monthly Versus Quarterly Dutasteride Mesotherapy for Male Androgenetic Alopecia: A Randomized Trial Journal of the European Academy of Dermatology and Venereology · 2025
    2. The Safety and Efficacy of Finasteride for Transgender Men with Androgenetic Alopecia: A Case Series Journal of Medical Case Reports · 2025
    3. Use of Oral Minoxidil for Androgenetic Alopecia in Transgender and Gender-Diverse People: A Retrospective Study of 27 Patients Journal of the American Academy of Dermatology · 2025
    4. Use of Low-Dose Oral Minoxidil for Hair Growth in Transgender and Gender Non-Binary Adult Patients: A Retrospective Cohort Study Journal of the American Academy of Dermatology · 2025
    5. High-Dose Oral Minoxidil for the Treatment of Androgenetic Alopecia Actas Dermo-Sifiliográficas · 2025
    6. Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review Journal of Clinical Medicine · 2025
    7. Finasteride Use: Evaluation of Depression and Suicide Risk Journal of Cosmetic Dermatology · 2025
    8. Spironolactone Reduces the Risk of Low-Dose Oral Minoxidil-Induced Edema in Women with Female Pattern Hair Loss. Journal of the American Academy of Dermatology · 2025
    9. Scalp Hair Parameter Changes in Transgender Individuals Commencing Gender-Affirming Hormone Therapy: A 24-Week Prospective Observational Study Journal of the American Academy of Dermatology · 2025
    10. The Risk of Psychiatric Disorders in Finasteride Users with Benign Prostatic Hyperplasia and Androgenetic Alopecia: A Population-Based Case-Control Study Australasian Journal of Dermatology · 2024
    11. Impact of Finasteride and Dutasteride in Beard Thickness in Men with Androgenetic Alopecia: A 453-Patient Retrospective Trial Actas Dermo-Sifiliográficas · 2024
    12. Oral Minoxidil 7.5 mg for Hair Loss Increases Heart Rate with No Change in Blood Pressure in 24-Hour Holter and 24-Hour Ambulatory Blood Pressure Monitoring Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia · 2024
    13. Efficacy of Topical Minoxidil in Enhancing Beard Growth in Transgender Individuals Assigned Female at Birth on Gender Affirming Hormone Therapy Journal of endocrinological investigation · 2024
    14. Efficacy of Low-Dose Spironolactone for Hair Loss in Women PubMed · 2024
    15. Survey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia PubMed · 2024
    16. Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Document from the Spanish Trichology Group of the Spanish Academy of Dermatology and Venereology Actas Dermo-Sifiliográficas · 2023
    17. Review of Hair Prosthetic Options for Patients With Alopecia Journal of cosmetic dermatology · 2023
    18. Gender-Affirmation Hair Transplantation Techniques Facial Plastic Surgery Clinics of North America · 2023
    19. Australian Dermatologists' Prescribing Behaviours for Male Androgenetic Alopecia Australasian Journal of Dermatology · 2023
    20. Low-Dose Oral Minoxidil in the Treatment of Alopecia: Evidence and Experience-Based Consensus Statement of Indian Experts International Journal of Trichology · 2023
    21. US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know? European urology open science · 2023
    22. Compliance to Topical Minoxidil and Reasons for Discontinuation Among Patients With Androgenetic Alopecia Dermatology and therapy · 2023
    23. Androgenetic Alopecia Incidence In Transgender And Gender Diverse Populations: A Retrospective Comparative Cohort Study Journal of The American Academy of Dermatology · 2023
    24. The State-of-the-Art in the Management of Androgenetic Alopecia: A Review of New Therapies and Treatment Algorithms JEADV Clinical Practice · 2022
    25. Relative Efficacy of Minoxidil and the 5-Alpha Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients JAMA Dermatology · 2022
    26. Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study Transgender health · 2022
    27. Androgenetic Alopecia in Transgender and Gender Diverse Populations: A Review of Therapeutics Journal of The American Academy of Dermatology · 2021
    28. Efficacy and Safety of Topical Finasteride Spray Solution for Male Androgenetic Alopecia: A Phase III, Randomized, Controlled Clinical Trial Journal of The European Academy of Dermatology and Venereology · 2021
    29. Case Report: Successful Use of Minoxidil to Promote Facial Hair Growth in an Adolescent Transgender Male Frontiers in Endocrinology · 2021
    30. Efficacy and Safety Profile of Oral Spironolactone Use for Androgenic Alopecia: A Systematic Review PubMed · 2021
    31. Antiandrogen Therapy in Hidradenitis Suppurativa: Finasteride for Females Clinical and Experimental Dermatology · 2021
    32. Dermatologic Care of Hair in Transgender Patients: A Systematic Review of Literature Dermatology and therapy · 2021
    33. Incidence and Factors Associated With Androgenetic Alopecia Among Transgender and Gender-Diverse Patients Treated With Masculinizing Hormone Therapy JAMA Dermatology · 2021
    34. Combination Oral Minoxidil and Spironolactone for the Treatment of Androgenetic Alopecia in Adolescent Girls Journal of The American Academy of Dermatology · 2020
    35. Is There a Role for 5α-Reductase Inhibitors in Transgender Individuals? International Journal of Andrology · 2020
    36. Bicalutamide: A Potential New Oral Antiandrogenic Drug for Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2020
    37. Effectiveness and Safety of Oral Dutasteride for Male Androgenetic Alopecia in Real Clinical Practice: A Descriptive Monocentric Study Dermatologic Therapy · 2019
    38. Hair Loss Among Transgender and Gender-Nonbinary Patients: A Cross-Sectional Study British Journal of Dermatology · 2019
    39. The Efficacy and Safety of Dutasteride Compared with Finasteride in Treating Men with Androgenetic Alopecia: A Systematic Review and Meta-Analysis Clinical Interventions in Aging · 2019
    40. Hormonal Treatment of Transgender Women with Oral Estradiol Transgender health · 2018
    41. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women PubMed · 2018
    42. Androgens Trigger Different Growth Responses in Genetically Identical Human Hair Follicles in Organ Culture Reflecting Their Epigenetic Diversity in Life The FASEB Journal · 2017
    43. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology & Metabolism · 2017
    44. Therapeutic Experience with Oral Finasteride for Androgenetic Alopecia in Female-to-Male Transgender Patients Clinical and Experimental Dermatology · 2017
    45. Testosterone Therapy for Transgender Men: Effects and Safety The Lancet Diabetes & Endocrinology · 2016
    46. Scalp Hair Regrowth in Hormone-Treated Transgender Woman Transgender health · 2016
    47. Hair Regrowth in a Male Patient with Extensive Androgenetic Alopecia on Estrogen Therapy Journal of The American Academy of Dermatology · 2012
    48. 5 mg/Day Finasteride Treatment for Normoandrogenic Asian Women with Female Pattern Hair Loss Journal of The European Academy of Dermatology and Venereology · 2010